Aaron Wealth Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$881K Buy
20,643
+7,934
+62% +$431K 0.04% 279
2026
Q1
$797K Sell
12,709
-12,451
-49% -$996K 0.05% 276
2025
Q4
$2.4M Buy
25,160
+7,311
+41% +$717K 0.13% 104
2025
Q3
$1.74M Buy
17,849
+6,749
+61% +$699K 0.1% 129
2025
Q2
$1.19M Buy
11,100
+349
+3% +$35.3K 0.12% 117
2025
Q1
$1.08M Buy
10,751
+598
+6% +$60.2K 0.12% 114
2024
Q4
$907K Buy
10,153
+1,468
+17% +$129K 0.11% 129
2024
Q3
$728K Buy
8,685
+1,799
+26% +$142K 0.09% 147
2024
Q2
$530K Buy
6,886
+1,183
+21% +$86.6K 0.07% 162
2024
Q1
$391K Buy
5,703
+747
+15% +$48K 0.06% 186
2023
Q4
$287K Buy
4,956
+787
+19% +$42K 0.05% 197
2023
Q3
$220K Sell
4,169
-273
-6% -$14.3K 0.03% 235
2023
Q2
$240K Buy
+4,442
New +$232K 0.03% 229
2022
Q2
Sell
-68,162
Closed -$1.54M 281
2022
Q1
$1.54M Buy
+68,162
New +$2.95M 0.02% 276

Other funds holding BSX

Aaron Wealth Advisors's BSX Position: Q2 2026 in Review

Aaron Wealth Advisors increased its Boston Scientific (BSX) stake by 62% in Q2 2026, buying an estimated $431K and bringing the position to 20,643 shares worth $881K. The position accounts for 0.04% of the portfolio, ranked #279.

Aaron Wealth Advisors first reported a position in BSX in Q1 2022 and has held it in 14 quarters since. The position peaked at $2.4M in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Aaron Wealth Advisors held 20,643 shares of Boston Scientific worth $881K as of Q2 2026.
  • Aaron Wealth Advisors bought 7,934 Boston Scientific shares in Q2 2026, an estimated $431K.
  • Boston Scientific made up 0.04% of Aaron Wealth Advisors's portfolio in Q2 2026, its #279 holding.
  • Aaron Wealth Advisors first reported a position in Boston Scientific in Q1 2022 and has held it in 14 quarters since.
  • Aaron Wealth Advisors's Boston Scientific position peaked at $2.4M in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.